结核病感染结果的不准确性:对非劣势疫苗试验的影响
Daniel J Grint1, Richard G White1, Gavin Churchyard2,3,4
1Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
International journal of epidemiology
|March 5, 2026
概括
新的结核病疫苗正在试验中,这些试验可能会因为不完美的感染标志物而错误地宣称非劣势. 谨慎的设计和解释至关重要,以避免结核疫苗研究中的这种偏见.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 传染病流行病学 传染病流行病学
- 生物统计学 生物统计学
背景情况:
- 目前的结核病疫苗试验使用非劣势设计,结核病感染作为主要终点.
- 已建立的Bacille Calmette-Guérin (BCG) 疫苗是婴儿的标准做法.
- 目前存在的结核病感染标志物在敏感性和特异性方面具有局限性.
研究的目的:
- 评估不完善的结核感染标志物对解释非劣势疫苗试验的影响.
- 评估结核疫苗研究中错误地得出非劣等结论的风险.
主要方法:
- 进行了统计模拟研究.
- 模拟模拟了双臂随机比较,具有不同结核感染累积风险 (2%, 5%, 8%).
- 测试灵敏度在100%至64%之间,特异性在100%至85%之间.
主要成果:
- 完美的灵敏度和特异性产生了预期的I型错误和功率.
- 具有95%的灵敏度和特异性,错误声明非劣势的风险是相当大的 (96.8%的2%风险,53.2%的5%风险,27.8%的8%风险).
结论:
- 使用感染结果的结核疫苗非劣势试验容易产生偏见.
- 准确的解释需要考虑用于测量感染的诊断工具的性能.
- 如果未能解决标记者的限制,就有可能错误地声明非劣等.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
11.2K
08:10A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
14.3K
相关概念视频
Pulmonary Tuberculosis IV
588
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
588
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis V
704
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
704
